Paediatric Consumer Health in the US

Paediatric Consumer Health in the US

Paediatric consumer health is set to see a second year of retail current value decline in the US in 2024, with variations in performance across categories. For instance, paediatric cough, cold, and allergy remedies and paediatric analgesics are expected to see a second year of single-digit decline in 2024, following the dramatic double-digit growth rates seen during the “tripledemic” of 2022. The most significant decline will be seen in paediatric acetaminophen. This saw the highest growth rate...

Euromonitor International's Paediatric Consumer Health in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.